Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351156 · ClinicalTrials.gov registry record
Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease
A clinical trial, sponsored by Amicus Therapeutics.
- Completed
- Registry status
- 50
- Enrollment target
NCT00351156 is a clinical trial that has completed, run by Amicus Therapeutics. The registered enrollment target is 50 participants.
The verdict
NCT00351156 has completed, sponsored by Amicus Therapeutics.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about Gaucher disease. The information we collect from medical histories and a blood sample from people with Gaucher disease may help us pinpoint certain things that are different between people who have Gaucher disease and people who do not have Gaucher disease. This information may be useful in the future to help find new treatments for Gaucher disease.
Interventions
- PROCEDURE Blood sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00351156
The ClinicalTrials.gov registry entry for NCT00351156 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amicus Therapeutics, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood sample is the first listed.
NCT00351156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00351156 about?
NCT00351156 is a clinical study titled "Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease". The purpose of this study is to learn more about Gaucher disease. The information we collect from medical histories and a blood sample from people with Gaucher disease may help us pinpoint certain things that are different between people who have Gaucher disease and people who do not have Gaucher di...
What is the current status of trial NCT00351156?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2006-07. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00351156?
The interventions under investigation include: Blood sample (PROCEDURE).
Who is sponsoring clinical trial NCT00351156?
This trial is sponsored by Amicus Therapeutics, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.